Shorted
Acrux logo
ACR
Pharmaceuticals, Biotechnology & Life Sciences

Acrux

Short interest
0.21%
+0.20 pp 30d
as of 6 Dec 2024
Reported shorts
611.8K
Shares on issue
290.717M

Acrux (ACR) company profile

Profile, insiders and operations

Company

AI-generated research profile of Acrux

pharmaceuticals
biotechnology
transdermal delivery
drug development
ASX

Acrux Limited is a leading Australian company in the pharmaceutical industry, specializing in the development and commercialization of topical and transdermal drug delivery systems. These innovative solutions are aimed at enhancing the efficiency and effectiveness of drug administration through the skin. With strong ties to scientific research and robust market distribution channels, Acrux positions itself as a pioneer in the transdermal patch market.

Director trades

20 trades recorded

DateDirectorTypeSharesPriceValue
2026-09-14Geoffrey Brooke
exercise options
4,109,653--
2026-09-14Unknown Director
buy
---
2026-09-03Don Brumley
exercise options
3,116,679--
2026-09-03John Warmbrunn
buy
3,750,000--
2026-09-03Tim Oldham
buy
2,400,000--
2026-09-03Geoffrey Brooke
buy
2,400,000--
2026-09-03Ross Dobinson
buy
4,800,000--
2026-09-03Unknown Director
buy
---
2026-09-03Unknown Director
buy
---
2026-09-03Unknown Director
buy
---
2026-09-03Unknown Director
buy
---
2026-09-03Unknown Director
buy
---
2026-07-24Ross Dobinson
buy
1,128,565--
2026-07-24Unknown Director
buy
---
2026-06-02Don Brumley
exercise options
1,433,360--
2026-06-02Unknown Director
buy
---
2026-06-02Unknown Director
buy
---
2026-06-02Unknown Director
buy
---
2026-06-02Tim Oldham
exercise options
1,433,360--
2026-06-02Ross Dobinson
exercise options
4,925,678--

ACR intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required